PP
BMY icon

Paloma Partners’s Bristol-Myers Squibb BMY Stock Holding History

Paloma Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-53,200
Closed -$2.21M – 1187
2024
Q2 		$2.21M Buy
+53,200
New +$2.38M 0.06% 326
2024
Q1 		– Sell
-144,500
Closed -$7.41M – 797
2023
Q4 		$7.41M Sell
144,500
-147,500
-51% -$7.74M 0.27% 59
2023
Q3 		$16.9M Buy
292,000
+95,000
+48% +$5.82M 0.59% 25
2023
Q2 		$12.6M Buy
197,000
+154,200
+360% +$10.3M 0.45% 29
2023
Q1 		$2.97M Sell
42,800
-55,700
-57% -$3.93M 0.1% 167
2022
Q4 		$7.09M Buy
+98,500
New +$7.43M 0.33% 46
2019
Q4 		– Sell
-28,000
Closed -$1.42M – 2160
2019
Q3 		$1.42M Buy
28,000
+23,400
+509% +$1.1M 0.03% 574
2019
Q2 		$209K Buy
+4,600
New +$214K ﹤0.01% 1518
2018
Q3 		– Sell
-44,700
Closed -$2.47M – 1564
2018
Q2 		$2.47M Buy
+44,700
New +$2.41M 0.05% 368
2018
Q1 		– Sell
-100,900
Closed -$6.18M – 1953
2017
Q4 		$6.18M Buy
100,900
+26,200
+35% +$1.64M 0.08% 217
2017
Q3 		$4.76M Buy
+74,700
New +$4.36M 0.07% 299
2017
Q1 		– Sell
-3,800
Closed -$222K – 1966
2016
Q4 		$222K Sell
3,800
-21,000
-85% -$1.15M ﹤0.01% 1806
2016
Q3 		$1.34M Sell
24,800
-624,400
-96% -$40.1M 0.02% 792
2016
Q2 		$47.7M Buy
649,200
+551,600
+565% +$39M 0.53% 19
2016
Q1 		$6.23M Buy
97,600
+73,600
+307% +$4.64M 0.1% 136
2015
Q4 		$1.65M Buy
24,000
+16,000
+200% +$1.06M 0.04% 440
2015
Q3 		$474K Sell
8,000
-344,700
-98% -$21.9M 0.01% 1054
2015
Q2 		$23.5M Buy
+352,700
New +$23.2M 0.45% 37

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paloma Partners's BMY Position: Q3 2024 in Review

Paloma Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 31,190 shares — an estimated $1.3M sold.

Paloma Partners first reported a position in BMY in Q2 2013 and held it in 34 quarters. The position peaked at $14.6M in Q2 2020. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Paloma Partners reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 31,190 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.3M.
  • Paloma Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 34 quarters.
  • Paloma Partners's Bristol-Myers Squibb position peaked at $14.6M in Q2 2020.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.